Peter S Garcia's Net Worth
$4.38 Million
Who is Peter S Garcia?
Peter S Garcia has an estimated net worth of $4.38 Million. This is based on reported shares across multiple companies, which include MDRNA, Inc., BIOTIME INC, ALX ONCOLOGY HOLDINGS INC, DURECT CORP, PDL BIOPHARMA, INC., and NUVELO INC.
SEC CIK
Peter S Garcia's CIK is 0001188956
Past Insider Trading and Trends
2015 was Peter S Garcia's most active year for acquiring shares with 9 total transactions. Peter S Garcia's most active month to acquire stocks was the month of July. 2021 was Peter S Garcia's most active year for disposing of shares, totalling 32 transactions. Peter S Garcia's most active month to dispose stocks was the month of July. 2017 saw Peter S Garcia paying a total of $483,246.11 for 237,669 shares, this is the most they've acquired in one year. In 2021 Peter S Garcia cashed out on 186,128 shares for a total of $6,522,359.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MDRNA, Inc. (ATRX) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
$0.60 | $3,000.00 | 5K |
Mar 31 - Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOTIME INC (LCTX) Snapshot price: $0.8778
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +250.00% | 5K |
$4.68 | $23,378.50 | 7K |
Mar 19
| |||
Form 4
|
∞
| 2K |
$4.17 | $8,340.00 | 2K |
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $1.91
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.62% | -761.00 |
$2.58 | -$1,963.38 | 121.52K |
Aug 14
| |||
Form 4
| -1.44% | -1.79K |
$6.03 | -$10,787.67 | 122.28K |
Jun 28
| |||
Form 4/A
| +10.87% | 12K |
$8.53 | $102,338.40 | 122.35K |
Jun 13
| |||
Form 4
| +10.87% | 12K |
$8.53 | $102,338.40 | 122.35K |
Jun 13
| |||
Form 4
| +29.29% | 25K |
—
|
—
| 110.35K |
Feb 14
| |||
Form 4
| -2.17% | -1.89K |
$15.04 | -$28,470.72 | 85.35K |
Dec 29
| |||
Form 4
| +58.46% | 32K |
—
|
—
| 86.74K |
Jul 25
| |||
Form 4
| -1.59% | -887.00 |
$7.34 | -$6,510.58 | 54.74K |
Jun 30
| |||
Form 4
| -1.64% | -893.00 |
$11.07 | -$9,885.60 | 53.72K |
Dec 29
| |||
Form 4
| +110.78% | 29K |
—
|
—
| 55.18K |
Aug 5
| |||
Form 4
| +158.18% | 15K |
$4.49 | $67,304.99 | 24.48K |
Feb 7
| |||
Form 4
|
—
|
0
|
$29.76 | -$371,298.83 | 9.33K |
Scheduled
|
Oct 18
| ||
Form 4
|
—
|
0
|
$41.61 | -$958,400.21 | 9.33K |
Scheduled
|
Sep 16 - Sep 17
| ||
Form 4
|
—
|
0
|
$39.12 | -$4,203,961.78 | 9.33K |
Scheduled
|
Aug 23
| ||
Form 4
|
—
|
0
|
$35.16 | -$621,498.67 | 9.33K |
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
| +204.27% | 6.13K |
$4.08 | $25,002.24 | 9.13K |
Jan 28
| |||
Form 4
|
∞
| 3K |
$19.00 | $57,000.00 | 3K |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DURECT CORP (DRRX) Snapshot price: $1.5699
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
Vice President, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
| -50.55% | -230.00K |
$3.02 | -$10,730.06 | 225.03K |
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -3.77% | -17.82K |
—
|
—
| 455.02K |
Dec 15
| |||
Form 4
| +5.58% | 25K |
$1.98 | $49,401.35 | 472.84K |
Mar 24
| |||
Form 4
| +90.43% | 212.67K |
$2.04 | $433,844.76 | 447.84K |
Mar 4
| |||
Form 4
| -0.81% | -1.92K |
—
|
—
| 235.17K |
Dec 13
| |||
Form 4
| +4.40% | 10K |
$3.00 | $29,950.00 | 237.09K |
Aug 9
| |||
Form 4
| +80.17% | 101.05K |
$3.22 | $325,384.22 | 227.09K |
Jan 26
| |||
Form 4
| +13.51% | 15K |
$3.50 | $52,444.50 | 126.04K |
Dec 14 - Dec 15
| |||
Form 4
| +15.82% | 15.17K |
$4.95 | $75,086.55 | 111.04K |
Sep 29
| |||
Form 4
| +26.36% | 20K |
$5.83 | $116,501.98 | 95.87K |
Aug 13 - Aug 14
| |||
Form 4
| +76.34% | 32.85K |
$7.62 | $250,294.14 | 75.87K |
Jan 28
| |||
Form 4
| +242.15% | 30.45K |
$8.22 | $250,299.00 | 43.02K |
Apr 10
| |||
Form 4
|
∞
| 12.57K |
$8.35 | $105,001.25 | 12.57K |
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||